Inhibrx Biosciences (INBX) Short Interest
Nasdaq • INBX • US45720N1037
As of Oct 22, 2026, ORTEX estimated 40% of free float sold short, 16.1 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
Nasdaq • INBX • US45720N1037
As of Oct 22, 2026, ORTEX estimated 40% of free float sold short, 16.1 days to cover, cost to borrow 0.46%. Sign up for live short interest data.
This page tracks how heavily Inhibrx Biosciences (Nasdaq:INBX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Inhibrx Biosciences (Nasdaq: INBX) has a market capitalization of $1.24B. Last close $84.52 (as of 2026-11-09); 52-week range $57.30 to $155.29. ORTEX data as of 2026-10-22: short interest was 40.01% of free float, 16.1 days to cover and the average cost to borrow was 0.46%. Sign up for live short interest data.